6Q1 Stock Overview
Omda AS provides software solutions for healthcare sector in Norway, Sweden, Denmark, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 2/6 |
| Past Performance | 2/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Omda AS Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr3.00 |
| 52 Week High | kr4.22 |
| 52 Week Low | kr1.95 |
| Beta | 0.71 |
| 1 Month Change | 4.17% |
| 3 Month Change | 9.09% |
| 1 Year Change | -12.02% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -63.19% |
Recent News & Updates
Recent updates
Shareholder Returns
| 6Q1 | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | 3.1% | 1.0% | -1.0% |
| 1Y | -12.0% | -23.9% | 2.0% |
Return vs Industry: 6Q1 exceeded the German Healthcare Services industry which returned -23.9% over the past year.
Return vs Market: 6Q1 underperformed the German Market which returned 2% over the past year.
Price Volatility
| 6Q1 volatility | |
|---|---|
| 6Q1 Average Weekly Movement | 11.2% |
| Healthcare Services Industry Average Movement | 3.6% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 6Q1's share price has been volatile over the past 3 months.
Volatility Over Time: 6Q1's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 291 | Sverre Flatby | www.omda.com |
Omda AS provides software solutions for healthcare sector in Norway, Sweden, Denmark, and internationally. The company offers laboratory information management systems consist of CSAM ProSang, a blood, cell, and tissue management system; and medical medication solution comprising CSAM Cytodose, an oncology treatment management solution. It also provides connected healthcare solutions, including Omda Cardio, an ECG and diagnostic storage tool; Omda CIMA, a medical imaging mobile app; Omda Media, a web-based medical imaging solution; Omda Medimaker, an image management and workflow; Omda Picsara, an image management solution; Omda Arcidis, an integrated teleradiology system; Omda Helsemail, an patient data transfer tool; Omda Plutus, audit and workflow monitoring platform; Omda S7, a secure e-care communications platform; and Omda XDS, patient data storage and management solution.
Omda AS Fundamentals Summary
| 6Q1 fundamental statistics | |
|---|---|
| Market cap | €62.66m |
| Earnings (TTM) | €8.92m |
| Revenue (TTM) | €35.47m |
7.0x
P/E Ratio1.8x
P/S RatioIs 6Q1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 6Q1 income statement (TTM) | |
|---|---|
| Revenue | kr415.07m |
| Cost of Revenue | kr247.70m |
| Gross Profit | kr167.38m |
| Other Expenses | kr63.03m |
| Earnings | kr104.35m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 5.11 |
| Gross Margin | 40.32% |
| Net Profit Margin | 25.14% |
| Debt/Equity Ratio | 501.3% |
How did 6Q1 perform over the long term?
See historical performance and comparison